OR WAIT null SECS
May 03, 2012
AstraZeneca's CEO David Brennan To Retire; PRA, Amgen Reach New Biosimilar Agreement; and More.
April 05, 2012
On Mar. 29, 2012, the Generic Pharmaceutical Association reiterated its call for Congress to move forward with user-fee proposals for generic drugs and biosimilar products.
March 15, 2012
AstraZeneca Files Suit Against FDA; Pfizer, Biocon Terminate Biosimilar Alliance; and More.
March 08, 2012
BASi Restructures; Celerion, Ricerca Biosciences Form Biosimilars Alliance; and More.
March 02, 2012
Has the long-awaited guidance answered all of the industry's questions?
March 01, 2012
JHS Secures Four Sterile Parenteral Products Manufacturing Contracts; Samsung Biologics, Biogen Idec Establish Biosimilars Joint Venture; and More.
December 08, 2011
Samsung and Biogen Idec agreed to invest $300 million to establish a joint venture to develop, manufacture, and market biosimilars. The deal is Samsung's latest effort to strengthen its position in biosimilars.
On Dec. 6, 2011, FDA announced that a public meeting will be held on Dec. 16, 2011 to discuss recommendations for a user fee program for biosimilar biological products for fiscal years 2013–2017.
December 07, 2011
Biosimilar manufacturers need better expression systems and analytical tools to compete.
November 02, 2011